Welcome to the official website of Unipharm pharmaceutical industry Co., Ltd.!
Focus on research and development of new active pharmaceutical ingredients, pharmaceutical intermediates, APIs and other specialty chemicals
Pharmaceutical Intermediates Heterocyclic Block Organic Block
Home> Pharmaceutical Intermediates>Antineoplastic Agents> Irudinib Intermediate
Irutinil Is A Selective And Irreversible Btk Inhibitor With Ic50 Value Of 0.5 Nm. It Is A Small Molecule Drug That Permanently Binds To Bruton Tyrosine Kinase (Btk), An Important Protein In B Cells. Irutinil Is Used To Treat B-Cell Cancer, Such As Mantle
No data